Our research group uses the most modern genomic analysis techniques and state-of-the-art molecular and cell biology (omics technologies).
Through the combined analysis of genomes, transcriptomes, epigenomes, and integrative biology (cell culture, gene editing), GENVIP investigates the biological basis of infections using a novel host-based approach, and explores solutions for clinical practice.
GENVIP has set up a Clinical Trials Unit that is primarily focused on the field of vaccines. This unit channels most of the clinical trials conducted in Spain on pediatric vaccines, from Phase 1 to Phase 3. In addition, GENVIP partners with developers in the design of protocols and clinical development programs for a number of vaccine candidates.
GENVIP has established a series of national and international clinical networks of pediatric patients with infectious diseases. This enables the collection of a large amount of clinical data, as well as the creation of a large biobank, which are both key to the development of future scientific research.
GENVIP coordinates, among others, the Translational Research Network in Infectious Diseases [Red deInvestigación Traslacional en Enfermedades Infecciosas (RITIP)] and the Spanish Network of Pediatric ClinicalTrials [Red Española de Ensayos Clínicos Pediátricos (RECLIP)].
Management/Administrative and project management staff, Coordination are located on the first floor of the Hospital’s D Building, together with the Clinical Trials Unit, which is also in the first floor of the D building.
The laboratory area of GENVIP group, Laboratorio 19, is located in the facilities of the Health Research Institute of Santiago (IDIS) within the University Hospital Complex of Santiago de Compostela, which also houses other common work areas for IDIS researchers:
Common equipment rooms andplatforms
IDIS currently houses more than 90 research groups with more than 1,000 researchers. Its infrastructure is designed to suit the flexibility, dynamism and interdisciplinary interactions of modern biomedical research, and promote synergies between the different research groups of the Institute.
GENVIP’s laboratory is equipped with state-of-the-art research technology in order to contribute to scientific knowledge, both in basic and clinical research, always from a translational perspective and placing the patient and their benefit at the center of our mission.
GENVIP's laboratory is equipped with the following technology:
Transcriptomics, genomics and data analysis platform:
Sequencer MinION+Flongle+Voltrax de Oxford Nanopore (NGS)
Biosafety cabinet Class II A2
Basic laboratory equipment: stirrers, dry block heaters, vortex, centrifuges, slab heating ovens